BackAinos Overview

Ainos Profit Margin

Valuation check: AIMD's profit margin is -106283.32%, below the Healthcare sector average of 14.41%.

Get informed when a big investor buys or sells

+ Follow

Quarterly Profit Margin

-3022849.34%
3350.57% YoY

As of Jun 2026

Annual Profit Margin (TTM)

-106283.32%
649.39% YoY

Trailing 12 months ending Jun 2026

Average Profit Margin (Comparison Companies)

Loading

Profit Margin History

Loading

Profit Margin Comparison

Loading

Annual Profit Margin Growth Rate (%)

Loading

Ainos (AIMD) FAQ

The latest profit margin for AIMD is -106283.32% as of June 2026. That compares with -14182.68% in the prior-year period — down 649.4% year over year. That is below the Healthcare sector average of 14.41%. Investors often review this figure alongside Ainos's historical trend and sector peers before judging valuation or financial health.

Over the past year, AIMD's profit margin moved from -14182.68% to -106283.32% — a 649.4% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Ainos's valuation or profitability profile.

Against Healthcare companies, AIMD currently prints -106283.32% for profit margin, while the sector average sits near 14.41%. That is roughly 737421.6% below the sector mean. Large gaps often invite a closer look at Ainos's growth, margins, and balance sheet.

Profit Margin shows how effectively Ainos converts resources into returns. At -106283.32%, AIMD may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -14182.68% in the prior-year period — down 649.4% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting AIMD's profit margin (-106283.32%), review year-over-year change from -14182.68%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.